Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (81-90 of 743) with videos related to

Pageof 75
Sort By:
European Journal of Dermatology : EJD|March 2, 2002
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patientLucie Heinzerling, Reinhard Dummer, Günter Burg, et al.
Journal of Cutaneous Pathology|July 16, 2009
Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasmsJivko Kamarashev, Lars E French, Reinhard Dummer, et al.
Journal of Dermatological Science|March 14, 2015
Hedgehog signaling in basal cell carcinomaAtsushi Otsuka, Mitchell P Levesque, Reinhard Dummer, et al.
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Escalation and de-escalation of therapy for high-risk melanomas]Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, et al.
Dermatology (Basel, Switzerland)|August 18, 2017
Successful Use of Grenz Rays for Disseminated Superficial Actinic Porokeratosis: Report of 8 CasesEgle Ramelyte, Matilda Bylaite-Bucinskiene, Reinhard Dummer, et al.
Experimental Dermatology|November 28, 2022
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapyJulia Elisabeth Fromme, Reinhard Dummer, Cornelia Mauch, et al.
Seminars in Oncology|April 10, 2012
Recent advances in the management of cutaneous lymphomasBenedetta Belloni, Naomi Johansen, L Frank Glass, et al.
Skin Pharmacology and Physiology|September 30, 2009
New and experimental skin-directed therapies for cutaneous lymphomasArpad Farkas, Lajos Kemeny, Lars E French, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2017
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumorsReinhard Dummer, Christoph Hoeller, Isabella Pezzani Gruter, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutationsSimone M Goldinger, Carla Murer, Pascale Stieger, et al.
Pageof 75

Showing results (81-90 of 743) with videos related to

Sort By:
Pageof 75
European Journal of Dermatology : EJD|March 2, 2002
Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patientLucie Heinzerling, Reinhard Dummer, Günter Burg, et al.
Journal of Cutaneous Pathology|July 16, 2009
Symplastic glomus tumor - a rare but distinct benign histological variant with analogy to other 'ancient' benign skin neoplasmsJivko Kamarashev, Lars E French, Reinhard Dummer, et al.
Journal of Dermatological Science|March 14, 2015
Hedgehog signaling in basal cell carcinomaAtsushi Otsuka, Mitchell P Levesque, Reinhard Dummer, et al.
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Escalation and de-escalation of therapy for high-risk melanomas]Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, et al.
Dermatology (Basel, Switzerland)|August 18, 2017
Successful Use of Grenz Rays for Disseminated Superficial Actinic Porokeratosis: Report of 8 CasesEgle Ramelyte, Matilda Bylaite-Bucinskiene, Reinhard Dummer, et al.
Experimental Dermatology|November 28, 2022
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapyJulia Elisabeth Fromme, Reinhard Dummer, Cornelia Mauch, et al.
Seminars in Oncology|April 10, 2012
Recent advances in the management of cutaneous lymphomasBenedetta Belloni, Naomi Johansen, L Frank Glass, et al.
Skin Pharmacology and Physiology|September 30, 2009
New and experimental skin-directed therapies for cutaneous lymphomasArpad Farkas, Lajos Kemeny, Lars E French, et al.
Cancer Immunology, Immunotherapy : CII|February 27, 2017
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumorsReinhard Dummer, Christoph Hoeller, Isabella Pezzani Gruter, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Targeted therapy in melanoma - the role of BRAF, RAS and KIT mutationsSimone M Goldinger, Carla Murer, Pascale Stieger, et al.
Pageof 75